Proxy Votes Now

Home › Funds › Virtus › Virtus KAR Small-Mid Cap Growth Fund

Virtus KAR Small-Mid Cap Growth Fund (VAKSX) proxy voting record 2025-2026

Fund family: Virtus · Filed by VIRTUS EQUITY TRUST (CIK 34273) · SEC series S000070232

Share classes and tickers: VAKSX (C000223339), VCKSX (C000223336), VIKSX (C000223337), VRKSX (C000223338)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 267 with, 4 against, 0 abstentions (not counted as with management). Shareholder proposals: 1 FOR, 3 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Virtus as a whole

The same two figures as Virtus’s manager page (46,367 ballot items across 77 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsVirtusItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)97.3%26193.4%39,201
Backed environmental and social shareholder proposals at US companiesn/a08.6%1,030

Where this fund voted differently from most Virtus funds

Each ballot item this fund voted is set against the votes of the other Virtus funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most Virtus funds on all 195 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 95.6% of this fund’s 271 such votes could be given a sector; the other 12 (4.4%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Technology7322.7%
Consumer Discretionary6900.0%
Health Care3912.6%
Industrials3500.0%
Finance3113.2%
Consumer Staples1200.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections2030
Audit-related270
Say-on-Pay260
Corporate Governance84
Compensation70
Shareholder Rights and Defenses20

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
West Pharmaceutical Services, Inc.May 4, 2026$911,967141
HEICO CorporationMarch 13, 2026$872,141110
Teledyne Technologies IncorporatedApril 22, 2026$669,98160
HealthEquity, Inc.June 25, 2026$626,016140
Hinge Health, Inc.June 3, 2026$566,42430
Simpson Manufacturing Co., Inc.May 6, 2026$493,744100
Ryan Specialty Holdings, Inc.April 28, 2026$490,17570
LeMaitre Vascular, Inc.June 2, 2026$483,46940

Notable votes against management

MeetingCompanyProposalFundMgmt
May 4, 2026West Pharmaceutical Services, Inc.Shareholder proposal regarding an independent Board Chair policy. Shareholder proposalForAgainst
November 12, 2025Jack Henry & Associates, Inc.Stockholder proposal titled "Improved Shareholder Ability to Call for a Special Shareholder Meeting" Shareholder proposalAgainstFor
May 19, 2026Verisk Analytics, Inc.Shareholder Proposal - Shareholder Right to Act by Written Consent. Shareholder proposalAgainstFor
May 12, 2026TransUnionAdvisory vote on a stockholder proposal requesting a stockholder right to call a special meeting. Shareholder proposalAgainstFor

Search this fund’s votes by company

273 ballot items at 27 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Virtus KAR Small-Mid Cap Growth Fund (VAKSX) voted at 27 shareholder meetings of 27 companies, on 273 ballot items in all. Where management made a recommendation, the fund followed it on 98.5% of the items and voted against it 4 times. Its most frequent area of disagreement was corporate governance (4 of its votes against management). It voted on 4 shareholder proposals. It voted FOR the board's own proposals more often than Virtus's funds as a whole (97.3% against 93.4%). It voted the same way as most Virtus funds on every item where a comparison was possible.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Virtus’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.